ROIV vs SO · rev $29.1M vs P/E 22, rev $29.55B
Roivant Sciences Ltd (ROIV) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
Roivant Sciences Ltd (ROIV) is a biotechnology company listed on US.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Latest reported ROIV revenue for 2025-03-31 was $29.1M. Net income was -$356.7M. Revenue was down 11.2% from 2024-03-31 to 2025-03-31. ROIV currently screens at market cap $7.47B.
Latest reported SO revenue for 2025-12-31 was $29.55B. Net income was $4.34B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SO currently screens at market cap $101.55B and trailing P/E 22.1.
ROIV currently screens at market cap $7.47B. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the ROIV and SO stock pages for the full models.
Not investment advice.